Intelligence · Clinical Pipeline
Sanofi Pasteur MSD Pipeline
All ClinicalTrials.gov programs at Sanofi Pasteur MSD — phase, modality, and trial IDs.
- Programs
- 15
Quick answer
Sanofi Pasteur MSD has 15 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Bacillus Clausii Multi ATB Resist
Sanofi Pasteur
Diarrhea, Infantile
1 trial -
Dupilumab
Sanofi Pasteur
Asthma
2 trials -
Enoxaparin
Sanofi Pasteur
Acute Illness
1 trial -
Fexofenadine
Sanofi Pasteur
Rhinitis, Allergic, Perennial
1 trial -
Fexofenadine HCL and pseudoephedrine HCL
Sanofi Pasteur
Rhinitis Allergic
1 trial -
INSULIN GLARGINE (HOE901)
Sanofi Pasteur
Diabetes Mellitus, Type 2
1 trial -
Insulin Glargine
Sanofi Pasteur
Diabetes Mellitus, Type 2
2 trials -
Insulin glulisine
Sanofi Pasteur
Diabetes Mellitus, Type 1
1 trial -
Lixisenatide (AVE0010)
Sanofi Pasteur
Diabetes Mellitus, Type 2
3 trials -
RAMIPRIL HOE498
Sanofi Pasteur
Coronary Artery Disease
1 trial -
Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
Sanofi Pasteur
Cholera
1 trial -
alglucosidase alfa
Sanofi Pasteur
Pompe Disease (Infantile-Onset)
1 trial -
alglucosidase alfa
Sanofi Pasteur
Pompe Disease
1 trial -
rFVIIIFc
Sanofi Pasteur
Hemophilia A With Inhibitors
1 trial -
risedronate sodium
Sanofi Pasteur
Osteoporosis, Postmenopausal
1 trial
Frequently asked questions
How many pipeline programs does Sanofi Pasteur MSD have?
15 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs